Published, presented and verified.
Anpac Bio has partnered with respected medical and research institutions, in China and the U.S., conducting multiple research studies.
Anpac-Bio-Abstract-Evaluation-of-a-Multi-Level-Multi-Parameter-Detection-Method-for-Digestive-System-Cancer-Diagnosis
Anpac-Bio-Abstract-Investigations-of-a-New-Diagnostics-Technology-for-Hepatocellular-Carcinoma-Screening
Anpac-Bio-Abstract-Investigations-of-an-Improved-Esophageal-Cancer-Diagnostics-Approach
Anpac-Bio-Abstract-Investigations-of-Breast-Cancer-Screening-Using-a-Novel-In-Vitro-Diagnostics-Technology
Anpac-Bio-Abstract-Investigations-on-Non-Small-Cell-Lung-Cancer-Screening
Cancer-differentiation-analysis-technology-as-a-novel-technology-for-cerebral-cancer-screening
Founded in 2008, Anpac Bio-Medical Science Co., Ltd. is drawing on expertise.
Cancer Research & Detection
Chemistry & Bio-chemistry
Nano-technology & Physics
Surface & Material Science
Engineering & Manufacturing
CDA technology is called “game-changing” in Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.
Read the full article